Idiopathic Multicentric Castleman Disease Presenting With Generalized Lymphadenopathy: A Case Report
5 affiliations
- 1Internal Medicine, Centenario Hospital Miguel Hidalgo, Aguascalientes, MEX
- 2Teaching and Research, Centenario Hospital Miguel Hidalgo, Aguascalientes, MEX
- 3Radiation Oncology, Centenario Hospital Miguel Hidalgo, Aguascalientes, MEX
- 4Anatomical Pathology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, MEX
- 5Medicine, Universidad Autónoma de Aguascalientes, Aguascalientes, MEX
Abstract
Idiopathic multicentric Castleman disease (iMCD) is a rare non-clonal lymphoproliferative disorder characterized by systemic immune dysregulation and generalized lymphadenopathy, often mimicking infectious, autoimmune, and neoplastic diseases. We present the case of a 66-year-old woman with hypothyroidism and significant unintentional weight loss who was admitted with progressive dyspnea, generalized weakness, hypotension, diffuse lymphadenopathy, bibasal crackles, and ascites. Initial evaluation revealed cytopenias, elevated inflammatory markers, acute kidney injury, electrolyte abnormalities, hypoalbuminemia, diffuse lymphadenopathy, bilateral pleural effusions, ascites, and anasarca. Persistent hypotension, renal dysfunction, refractory hyperkalemia, and low serum cortisol levels raised clinical suspicion of adrenal insufficiency.
After multiple initially non-diagnostic lymph node biopsies, a subsequent cervical lymph node biopsy demonstrated histopathological and immunophenotypic findings consistent with iMCD of the mixed histological subtype, with negative human herpesvirus 8 testing and no histological evidence of malignancy. The diagnosis was established according to the Castleman Disease Collaborative Network criteria after evaluation for infectious, autoimmune, and neoplastic mimics. Intravenous hydrocortisone led to hemodynamic stabilization, renal recovery, correction of hyperkalemia, and improvement in platelet counts. The patient subsequently received rituximab, cyclophosphamide, and prednisone, with an initially favorable clinical response. However, her subsequent course was complicated by right femoral artery thrombosis requiring above-knee amputation and, later, shock associated with an extended-spectrum beta-lactamase-producing Escherichia coli infection, as well as progressive renal failure requiring hemodialysis. This case highlights the diagnostic complexity of iMCD and the importance of integrating clinical, laboratory, imaging, and histopathological findings, particularly when probable adrenal insufficiency is part of the initial presentation.
Related
- Characteristics of idiopathic multicentric Castleman disease in Spain: results of the registry-based ARCANA multicenter study
- Kidney involvement in idiopathic multicentric Castleman disease-TAFRO syndrome: clinical spectrum, pathology and outcomes.
- Idiopathic Multicentric Castleman Disease Mimicking Sepsis and Autoimmune Disease in a Caribbean Patient
- Fixed-cycle oral pomalidomide/lenalidomide-based therapy is associated with durable treatment-free remission in idiopathic multicentric castleman disease with TAFRO syndrome: a single-center retrospective study
- Correspondence on “leptospirosis presenting with fever, jaundice, and generalized lymphadenopathy: a case report with diagnostic challenges”
BibTeX
@article{alvarado2026idiopathic,
title = {{Idiopathic Multicentric Castleman Disease Presenting With Generalized Lymphadenopathy: A Case Report}},
author = {Alma P Huerta Alvarado and Oliver Colis Arenas and Yesenia Ortega Flores and Marian Rodriguez Carrillo and Omar De los Santos Farrera and Verónica Y Campos Sánchez and Miguel Ángel Galindo López},
journal = {Cureus},
year = {2026},
month = oct,
doi = {10.7759/cureus.117853},
url = {https://doi.org/10.7759/cureus.117853},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Idiopathic Multicentric Castleman Disease Presenting With Generalized Lymphadenopathy: A Case Report
AU - Alma P Huerta Alvarado
AU - Oliver Colis Arenas
AU - Yesenia Ortega Flores
AU - Marian Rodriguez Carrillo
AU - Omar De los Santos Farrera
AU - Verónica Y Campos Sánchez
AU - Miguel Ángel Galindo López
PY - 2026
DA - 2026/10/13
JO - Cureus
DO - 10.7759/cureus.117853
UR - https://doi.org/10.7759/cureus.117853
AB - Idiopathic multicentric Castleman disease (iMCD) is a rare non-clonal lymphoproliferative disorder characterized by systemic immune dysregulation and generalized lymphadenopathy, often mimicking infectious, autoimmune, and neoplastic diseases. We present the case of a 66-year-old woman with hypothyroidism and significant unintentional weight loss who was admitted with progressive dyspnea, generalized weakness, hypotension, diffuse lymphadenopathy, bibasal crackles, and ascites. Initial evaluation revealed cytopenias, elevated inflammatory markers, acute kidney injury, electrolyte abnormalities, hypoalbuminemia, diffuse lymphadenopathy, bilateral pleural effusions, ascites, and anasarca. Persistent hypotension, renal dysfunction, refractory hyperkalemia, and low serum cortisol levels raised clinical suspicion of adrenal insufficiency. After multiple initially non-diagnostic lymph node biopsies, a subsequent cervical lymph node biopsy demonstrated histopathological and immunophenotypic findings consistent with iMCD of the mixed histological subtype, with negative human herpesvirus 8 testing and no histological evidence of malignancy. The diagnosis was established according to the Castleman Disease Collaborative Network criteria after evaluation for infectious, autoimmune, and neoplastic mimics. Intravenous hydrocortisone led to hemodynamic stabilization, renal recovery, correction of hyperkalemia, and improvement in platelet counts. The patient subsequently received rituximab, cyclophosphamide, and prednisone, with an initially favorable clinical response. However, her subsequent course was complicated by right femoral artery thrombosis requiring above-knee amputation and, later, shock associated with an extended-spectrum beta-lactamase-producing Escherichia coli infection, as well as progressive renal failure requiring hemodialysis. This case highlights the diagnostic complexity of iMCD and the importance of integrating clinical, laboratory, imaging, and histopathological findings, particularly when probable adrenal insufficiency is part of the initial presentation.
SN - 2168-8184
ER -